Zurich Cantonal Bank
CRBU icon

Zurich Cantonal Bank’s Caribou Biosciences CRBU Stock Holding History

Zurich Cantonal Bank’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,498
Closed -$39.8K – 2813
2023
Q1 		$39.8K Hold
7,498
– – ﹤0.01% 2637
2022
Q4 		$47.1K Sell
7,498
-2,987
-28% -$26.6K ﹤0.01% 2620
2022
Q3 		$111K Hold
10,485
– – ﹤0.01% 2134
2022
Q2 		$57K Buy
+10,485
New +$80.2K ﹤0.01% 2532

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Zurich Cantonal Bank's CRBU Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of Caribou Biosciences (CRBU) in Q2 2023, closing a stake of 7,498 shares — an estimated $39.8K sold.

Zurich Cantonal Bank first reported a position in CRBU in Q2 2022 and held it in 4 quarters. The position peaked at $111K in Q3 2022. 121 funds tracked by Wall St. Rank hold CRBU as of Q2 2023.

  • Zurich Cantonal Bank reported no remaining Caribou Biosciences position as of Q2 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 7,498 Caribou Biosciences shares in Q2 2023, an estimated $39.8K.
  • Zurich Cantonal Bank first reported a position in Caribou Biosciences in Q2 2022 and held it in 4 quarters.
  • Zurich Cantonal Bank's Caribou Biosciences position peaked at $111K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.